Rare diseases
Investigational molecules
Locations
138 conditions with trials, the busiest first
373 trials across Europe, recruiting first
FranceStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
AustriaStudy on Atropine Sulfate Eye Drops to Slow Down Myopia in European Children
GermanyStudy of AloCelyvir for Patients with Metastatic Uveal Melanoma
SpainStudy on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration
CzechiaStudy on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder
The NetherlandsStudy of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson's Disease
DenmarkStudy on Long-Term Safety and Effects of SAR421869 for Patients with Usher Syndrome Type 1B
FranceStudy on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration
CzechiaStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on Elamipretide for Patients with Dry Age-Related Macular Degeneration (Dry AMD)
CzechiaStudy of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg
AustriaThe therapies tested most often in Eye disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
